These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16534358

  • 21. Management of hepatorenal syndrome.
    McCormick PA, Donnelly C.
    Pharmacol Ther; 2008 Jul; 119(1):1-6. PubMed ID: 18539334
    [Abstract] [Full Text] [Related]

  • 22. Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature.
    Gur C, Ilan Y, Shibolet O.
    Liver Int; 2004 Aug; 24(4):281-4. PubMed ID: 15287850
    [Abstract] [Full Text] [Related]

  • 23. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX, Jain AB, Orloff MS.
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [Abstract] [Full Text] [Related]

  • 24. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
    Kim JJ, Dasika NL, Yu E, Fontana RJ.
    Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981
    [Abstract] [Full Text] [Related]

  • 25. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM.
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I, Kelekis DA, Karatza C, Nikolaou V, Mouyia V, Brountzos EN.
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [Abstract] [Full Text] [Related]

  • 28. New treatments of hepatorenal syndrome.
    Arroyo V, Terra C, Ginès P.
    Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
    [Abstract] [Full Text] [Related]

  • 29. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 30. Dynamic MR perfusion measurements before and after TIPS in cirrhotic patients with refractory ascites.
    Maleux G, De Keyzer F, Prinsloo J, Heye S, Nevens F, Marchal G.
    Acad Radiol; 2007 Nov; 14(11):1400-8. PubMed ID: 17964463
    [Abstract] [Full Text] [Related]

  • 31. [Hepatorenal syndrome].
    Mijac D, Kezić A, Stojimirović B.
    Srp Arh Celok Lek; 2007 Nov; 135(1-2):98-104. PubMed ID: 17503577
    [Abstract] [Full Text] [Related]

  • 32. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD, Hellinger JC, Kang BC.
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [Abstract] [Full Text] [Related]

  • 33. Portal hypertension.
    Garcia-Tsao G.
    Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
    [Abstract] [Full Text] [Related]

  • 34. Hepatic hydrothorax: pathophysiology diagnosis and management.
    Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI.
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1388-93. PubMed ID: 17645471
    [Abstract] [Full Text] [Related]

  • 35. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

  • 36. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P, Saad WE, Waldman D.
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [Abstract] [Full Text] [Related]

  • 37. [Hepatorenal syndrome].
    Radziszewski A, Sułowicz W.
    Przegl Lek; 2006 Oct; 63(7):573-8. PubMed ID: 17203812
    [Abstract] [Full Text] [Related]

  • 38. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V, Fernandez J, Ginès P.
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [Abstract] [Full Text] [Related]

  • 39. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
    Senzolo M, Patch D, Cholongitas E, Triantos C, Marelli L, Stigliano R, Dhillon A, Burroughs A.
    Transplantation; 2006 Jul 15; 82(1):132-5. PubMed ID: 16861953
    [Abstract] [Full Text] [Related]

  • 40. Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders.
    Huffmyer JL, Nemergut EC.
    Respir Care; 2007 Aug 15; 52(8):1030-6. PubMed ID: 17650360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.